Biome Australia Ltd
ASX:BIO
Intrinsic Value
Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. [ Read More ]
The intrinsic value of one BIO stock under the Base Case scenario is 0.07 AUD. Compared to the current market price of 0.31 AUD, Biome Australia Ltd is Overvalued by 78%.
Valuation Backtest
Biome Australia Ltd
Run backtest to discover the historical profit from buying and selling BIO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Biome Australia Ltd
| Current Assets | 6.5m |
| Cash & Short-Term Investments | 2m |
| Receivables | 2.3m |
| Other Current Assets | 2.2m |
| Non-Current Assets | 676.3k |
| PP&E | 676.3k |
| Other Non-Current Assets | -10 |
| Current Liabilities | 4.6m |
| Accounts Payable | 1.8m |
| Accrued Liabilities | 1.6m |
| Other Current Liabilities | 1.2m |
| Non-Current Liabilities | 384.1k |
| Long-Term Debt | 299.6k |
| Other Non-Current Liabilities | 84.4k |
Earnings Waterfall
Biome Australia Ltd
|
Revenue
|
10.2m
AUD
|
|
Cost of Revenue
|
-4m
AUD
|
|
Gross Profit
|
6.3m
AUD
|
|
Operating Expenses
|
-9m
AUD
|
|
Operating Income
|
-2.7m
AUD
|
|
Other Expenses
|
-169.3k
AUD
|
|
Net Income
|
-2.9m
AUD
|
Free Cash Flow Analysis
Biome Australia Ltd
BIO Profitability Score
Profitability Due Diligence
Biome Australia Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Biome Australia Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
BIO Solvency Score
Solvency Due Diligence
Biome Australia Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Biome Australia Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIO Price Targets Summary
Biome Australia Ltd
According to Wall Street analysts, the average 1-year price target for BIO is 0.16 AUD .
Shareholder Return
BIO Price
Biome Australia Ltd
| Average Annual Return | -21.22% |
| Standard Deviation of Annual Returns | 24.11% |
| Max Drawdown | -49% |
| Market Capitalization | 65.7m AUD |
| Shares Outstanding | 203 384 400 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.
Contact
IPO
Employees
Officers
The intrinsic value of one BIO stock under the Base Case scenario is 0.07 AUD.
Compared to the current market price of 0.31 AUD, Biome Australia Ltd is Overvalued by 78%.
You don't have any saved screeners yet
